Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia

NCT05405192 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI is leaving the University.

Conditions

Gestational Trophoblastic Neoplasia

Interventions

DRUG: Dostarlimab

Sponsor

University of Miami

Collaborators

[object Object]